Labubu fever, and a skincare brawl
An early edition toy based on the red-hot Labubu character has fetched a record $150,000 in a recent auction. What's driving the craze, and is it sustainable? And a high-profile tussle between two leading skincare brands has left one of them bruised, with its stock down 30%. How can investors steer clear of this kind of damage?
Biogene gets bruised in ‘Battle of the skincare belles’
A squabble involving false advertising claims by a sinking Bloomage Biotech against highflying rival Giant Biogene has captivated China, with no end in sight Key Takeaways: Shares of Giant Biogene…
Yatsen CEO declares turnaround with quarterly non-GAAP profit
The cosmetics seller reported a nearly 50% increase in its first-quarter revenue from skincare products as it pivots to the segment from make-up Key Takeaways: Yatsen’s first-quarter net loss narrowed…
Mao Geping’s Hong Kong IPO gets lift from regulatory nod
The planned listing by China’s second-ranking domestic cosmetics brand has been approved by the Mainland Chinese securities regulator Key Takeaways: Mao Geping’s Hong Kong IPO has been cleared by the…
Makeover complete? Yatsen says the worst may be behind it
The cosmetics and skincare company said it will boost its share repurchase plan, seeking to prop up its shares after it reported its revenue fell in the third quarter Key…
China’s Sun Protection Market Shines, and Not Just in Summer
Sales of sun protective products in China were worth nearly $4 billion in 2021, providing fertile new ground for traditional outdoor gear makers and a growing field of newcomers Key…